Skip to main content
. 2021 Oct 5;54:63. doi: 10.2340/16501977-2877

Fig. 1.

Fig. 1

Parameters considered by experts when selecting (a) intrathecal baclofen (ITB) or (b) botulinum toxin (BoNT) treatment for the management of disabling spasticity.